Study Finds ELISAs in Milk Samples Less Reliable for Johne’s Disease Detection — $198M in Dairy Losses Underscore Need for More Accurate Milk Testing
Peer-reviewed (in-press) study finds serum-based antibody tests align, but milk results vary—calling for improved milk-specific diagnostics to strengthen herd surveillance and profitability CARLSBAD, Calif., Oct. 29, 2025 /PRNewswire/ -- Pictor Holdings Inc. today announced new peer-reviewed data showing close agreement between commercial antibody tests when used on serum, but higher variability...
ICHORtec and Johns Hopkins University Expand Collaboration to Enhance CRISPR Gene Editing Specificity Using Quantum FMB® Technology
BERLIN and BALTIMORE, Oct. 29, 2025 /PRNewswire/ -- ICHORtec GmbH is pleased to announce an expanded research collaboration with the laboratory of Professor Gregory A. Newby in the Department of Genetic Medicine at the Johns Hopkins University School of Medicine. This partnership, aligned with the International Year of Quantum Science and Technology (IYQ) 2025, leverages ICHORtec's proprietary Quantum Fluorimetry of Molecular Binding (Q-FMB®) technology to...
“World Hair Transplant Repair Day” Taking Place on 11/11 Shines Light on Proliferation, Dangers of Black-Market Hair Transplant Clinics Worldwide
ISHRS Hosts Live Surgery Workshop in Bucharest, Romania, November 7-9, 2025, focusing on hair repair CHICAGO, Oct. 29, 2025 /PRNewswire/ -- According to a recent member survey conducted by the International Society of Hair Restoration Surgery (ISHRS), the impact of black-market hair transplant clinics continues to reverberate around the world – with more clinics...
IASO Bio Partners with Korea’s GC Cell to Bring CAR-T Therapy to Korea
Potential new treatment option for multiple myeloma patients in Korea. Expanded patient access through competitive pricing. SHANGHAI and NANJING, China and PLEASANTON, Calif., Oct. 29, 2025 /PRNewswire/ -- Nanjing IASO Biotechnology ("IASO Bio"), today announced that it has signed an agreement with Korea's GC Cell to introduce the CAR-T therapy "Fucaso" (Equecabtagene Autoleucel) to the South Korean market...
What Hebei Can Offer丨Biomedicine and Beyond
SHIJIAZHUANG, China, Oct. 29, 2025 /PRNewswire/ -- A News Report from Great Wall New Media -- Among Hebei Province's 107 key specialized industrial clusters, the biopharmaceutical cluster in Shijiazhuang High-Tech Zone has emerged as a model of high-quality development and a key engine driving Hebei's integration into the global health industry chain. The cluster has established a comprehensive industrial system covering R&D,...
Five social service agencies join Singapore’s shingles awareness movement
The first-of-its-kind community awareness movement, supported by GSK, aims to provide seniors and caregivers with information about shingles, its health risks, and available preventive measures. SINGAPORE, Oct. 29, 2025 /PRNewswire/ -- Five social service agencies — Diabetes Singapore, Lion Befrienders, Presbyterian Community Services, SASCO, and TOUCH Community Services —launched Singapore's first-of-its-kind shingles awareness movement at a 1960s/1970s nostalgia-themed event, "Shielding from...
Smartee and Straumann Announce Strategic Partnerships to Accelerate Innovation in Orthodontics
SHANGHAI, Oct. 29, 2025 /PRNewswire/ -- Smartee Denti-Technology and Straumann Group announce a strategic partnership. This partnership encompasses joint development of the next-generation orthodontics platform, co-innovation in clear aligner technologies, and a single-digit percentage of equity investment by Straumann into Smartee. Smartee and Straumann Announce Strategic Partnerships Junfeng Yao, Founder, President, and CEO...
Total Investment of Approx. USD 11.6 Million in TB and NTD R&D Projects With Partners Including Fujifilm, Stop TB Partnership, and the Ohio State University
TOKYO, Oct. 29, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.73 billion (USD 11.6 million1) in four R&D projects for the development of diagnostics and a vaccine for tuberculosis (TB), neglected tropical diseases (NTDs), and malaria.2 Investment of JPY 390 Million (USD 2.6 million1) to Advance a Novel Rapid Diagnostic...
VUNO Partners with European Firms to Advance DeepCARS® Market Entry in Europe
- Strategic MOU enhances market access and extends reach to over 900 hospitals across the region SEOUL, South Korea, Oct. 29, 2025 /PRNewswire/ -- VUNO Inc., a global medical AI company, announced today that it has signed a strategic Memorandum of Understanding (MOU) with Contextflow, an Austrian imaging AI company, and Mesalvo, a German hospital information system (HIS) provider,...
A Breakthrough in Color Measurement Is Coming: The HunterLab Agera L2
RESTON, Va., Oct. 29, 2025 /PRNewswire/ -- A breakthrough in color measurement is on the horizon. This November, HunterLab will unveil the Agera L2, the next generation in spectrophotometric innovation that will once again redefine how the world measures and perceives color. The Agera L2 represents a major advance in HunterLab's ongoing mission...
